Recombinant protein diannexin prevents preeclampsia-like symptoms in a pregnant mouse model via reducing the release of microparticles
Authors:
- 4 November 2022
- journal article
- research article
- Published by Springer Nature in Frontiers of Medicine
- Vol. 16 (6) , 1-13
Abstract
Preeclampsia (PE) is characterized by placenta-mediated pregnancy complication. The only effective treatment for PE is the delivery of the placenta. However, this treatment may cause preterm birth and neonatal death. Therefore, preventing PE is needed. The mechanism of PE involves abnormal placentation, which leads to the release of anti-angiogenic and inflammatory mediators into maternal circulation. These mediators contribute to systemic vascular dysfunction, inflammatory responses, and excessive thrombin generation. Microparticles (MPs) are reportedly involved in PE by promoting the thromboinflammatory response. This study describes a strategy to prevent PE by reducing MP release using the recombinant protein, diannexin. Results showed that the patients with PE had elevated MP number and procoagulant activity and increased NLRP3 inflammasome activation. Additionally, diannexin remarkably reduced the release of MPs from activated cells by binding to phosphatidylserine exposed on the surface of activated cells. Moreover, in vivo results showed that diannexin could prevent PE-like symptoms by decreasing MPs and NLRP3 inflammasome activation in pregnant mice. Furthermore, diannexin effectively inhibited trophoblast cell activation and NLRP3 inflammasome activation in vitro. These findings suggested that diannexin inhibited MP release and might be an effective therapeutic strategy for preventing PE.Keywords
This publication has 43 references indexed in Scilit:
- Loss of Maternal Annexin A5 Increases the Likelihood of Placental Platelet Thrombosis and Foetal LossScientific Reports, 2012
- Diannexin Protects against Renal Ischemia Reperfusion Injury and Targets Phosphatidylserines in Ischemic TissuePLOS ONE, 2011
- Tissue Factor–Bearing Microparticles and Thrombus FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1–Dependent Monocyte Adhesion and Transendothelial MigrationCirculation Research, 2011
- Engineered Annexin A5 Variants Have Impaired Cell Entry for Molecular Imaging of Apoptosis Using Pretargeting StrategiesJournal of Biological Chemistry, 2011
- Diannexin Decreases Inflammatory Cell Infiltration Into the Islet Graft, Reduces β-Cell Apoptosis, and Improves Early Graft FunctionTransplantation, 2010
- Feto-maternal interactions in pregnancies: Placental microparticles activate peripheral blood monocytesPlacenta, 2010
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Phosphatidylserine/Phosphatidylcholine Microvesicles Can Induce Preeclampsia-Like Changes in Pregnant MiceSeminars in Thrombosis and Hemostasis, 2005
- Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell EntryJournal of Biological Chemistry, 2004